Litcius/Paper detail

Interaction Between Serum/Glucocorticoid-Regulated Kinase 1 and Interleukin-6 in Chronic Rhinosinusitis

Yuting Lai, Li Hu, Yang Lu, Xianting Hu, Xiaole Song, Jingyi Yang, Hongbin Li, Kun Chen, Huabin Li, Dehui Wang

2021Allergy Asthma and Immunology Research10 citationsDOIOpen Access PDF

Abstract

PURPOSE: Serum/glucocorticoid-regulated kinase 1 (SGK1) has recently emerged as a critical regulator of inflammatory diseases. In this study, we examined SGK1 expression and its possible pathogenic roles in chronic rhinosinusitis (CRS). METHODS: . RESULTS: < 0.05). Administration of GSK650394, a SGK1 inhibitor, significantly increased IL-6 self-induced mRNA expression in cultured dispersed NP cells and 16HBE cells. CONCLUSIONS: The interaction between SGK1 and IL-6 may play an anti-inflammatory role in IL-6-induced inflammation in the pathogenesis of CRS.

Topics & Concepts

SGK1Gene knockdownNasal polypsLamina propriaMolecular biologyKinaseGlucocorticoidA549 cellMessenger RNAMedicineInterleukin 8BiologyCellCell cultureInflammationImmunologyPathologyEpitheliumCell biologyGeneBiochemistryGeneticsSinusitis and nasal conditionsInfectious Diseases and MycologyHead and Neck Surgical Oncology
Interaction Between Serum/Glucocorticoid-Regulated Kinase 1 and Interleukin-6 in Chronic Rhinosinusitis | Litcius